Pneumokoki - Sotsiaalministeerium
Pneumokoki - Sotsiaalministeerium
Pneumokoki - Sotsiaalministeerium
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Vaktsiinide efektiivsus ja ohutus (ptk 5)<br />
25. Black S, Shinefield H, Fireman B, et al. Efficacy, safety, and immunogenecity of<br />
heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J<br />
2000;19:187–95.<br />
26. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal<br />
conjugate vaccine in children younger than five years of age for prevention of<br />
pneumonia. Pediatr Infect Dis J 2002;21:810–5.<br />
27. CDC. Morbidity and Mortality Weekly Report. Direct and indirect effects of routine<br />
vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of<br />
invasive pneumococcal disease – United States, 1998-2003. CDC 2005;54(36).<br />
28. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against<br />
acute otitis media. N Eng J Med 2001;344(6):403–9.<br />
29. Esposito S, Tansey S, Thompson A, et al. Safety and immunogenicity of a 13-valent<br />
pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal<br />
conjugate vaccine given as a three-dose series with routine vaccines in healthy infants<br />
and toddlers. Clin Vaccine Immunol 2010;17(6):1017–26.<br />
30. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate<br />
vaccine on otitis media. Pediatr Infect Dis J 2003;22:10–6.<br />
31. Jansen AGSC, Hak E, Veenhoven RH, et al. Pneumococcal conjugate vaccines for<br />
preventing otitis media. Cochrane Database of Systematic Reviews 2009, Issue 2. Art.<br />
No.: CD001480. DOI: 10.1002/14651858.CD001480.pub3<br />
32. Kieninger DM, Kueper K, Steul K, et al. Safety, tolerability, and immunologic<br />
noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent<br />
pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.<br />
Vaccine 2010;28(25):4192–203.<br />
33. Käyhty H, Ahman H, Eriksson K, et al. Immunogenicity and tolerability of a heptavalent<br />
pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. Pediatr<br />
Infect Dis J 2005;24(2):108–14.<br />
34. Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for<br />
preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in<br />
children less than two years of age. Cochrane Database of Systematic Reviews 2009,<br />
Issue 4. Art. No.: CD004977. DOI: 10.1002/14651858.CD004977.pub2<br />
35. Pavia M, Bianco A, Nobile CG, et al. Efficacy of pneumococcal vaccination in children<br />
younger than 24 months: a meta-analysis. Pediatrics 2009;123(6):e1103–10.<br />
PC Vaktsiin_4.04 50
Change language